Autism spectrum disorder and neurodevelopmental delays in children with giant omphalocele

Space: StayCurrentMD Author: Enrico Danzer, Casey Hoffman, Judith S. Miller, Jo Ann D'Agostino, Erica M. Schindewolf, Marsha Gerdes, Judy Bernbaum, Samantha E. Adams, Natalie E. Rintoul, Lisa M. Herkert, Lynne Taylor, Jane Schreiber, William H. Peranteau, Alan W. Flake, N. Scott Adzi Published:

Author / Expert

Enrico Danzer, Casey Hoffman, Judith S. Miller, Jo Ann D'Agostino, Erica M. Schindewolf, Marsha Gerdes, Judy Bernbaum, Samantha E. Adams, Natalie E. Rintoul, Lisa M. Herkert, Lynne Taylor, Jane Schreiber, William H. Peranteau, Alan W. Flake, N. Scott Adzi

Topic overview

Abstract

Objective

To determine the prevalence and identify risk factors of autism spectrum disorders (ASDs) and neurodevelopmental delays in giant omphalocele (GO) survivors.

Materials and methods

The study cohort consists of 47 GO survivors enrolled in our follow-up program between 07/2004 and 12/2015. All patients underwent assessments at 2 years of age or older. Outcomes were assessed by either the Bayley Scales of Infant Development II (prior 2006) or III (after 2006), or the Wechsler Preschool and Primary Scale of Intelligence (children older than 4 years). ASD diagnosis was made based on the Diagnostic and Statistical Manual of Mental Disorders IV (prior to 2014) or 5 criteria.

Results

The prevalence of ASD in GO children is 16 times higher than the general population (P = 0.0002). ASD patients were more likely to be diagnosed with neurodevelopmental and neurofunctional delays, language disorders, and genetic abnormalities (P 

Keywords

Hashtags

2 Views
0 Comments

Comments

Loading comments...